Roche offers to buy out remaining Genentech shares for A$45 billion

Mediation and $20 million allows Biota and GSK to conclude litigation over Relenza

Australian and New Zealand researchers are part of an international project of mutual interest (and age-old bad jokes) - the sequencing of the sheep genome. The difference for the International Sheep Genomics Consortium is the availability of short-read sequencing technology.

James Watson's genome is now on DVD thanks to cutting-edge sequencing technology, so why, barring the wallaby genome, can't we do projects like this in Australia?

Bioscience companies are invited to attend a trade mission to Hong Kong.

$331 million deal sees Roche move into RNAi-based therapeutics.

Roche installs a Genome Sequencer FLX system in Australia.

A division of Roche Pharmaceuticals is holding a peptide chemistry conference later this year.

Roche Diagnostics has launched the second generation of its high throughput sequencing technology.

Swiss pharma giant Roche has made another big purchase, announcing it will by American biotech BioVeris for $750 million.

Roche Diagnostics is buying 454 Life Sciences, manufacturer of the 454 Sequencer.